
By DONALD G. McNEIL Jr.
NYT Health
The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.
Published date: May 9, 2019 at 03:00AM
No comments:
Post a Comment